Contact Information

Biography

Dr. Campbell was appointed as President, Chief Executive Officer, and a member of the Board of Directors on November 1, 2020, for the personalized healthcare company, Humanetix, Inc. Dr. Campbell currently serves as Executive Chairman of Mosaigen, a commercial development company, and RespaRx, a personalized medical device company. Dr. Campbell has over 30 years of successful experience with public and private companies in the life sciences, medical, health tech, nanotechnology, artificial intelligence, and high-performance computing technologies. Dr. Campbell has researched, developed, and commercialized over 275 products and/or services during his career. Dr. Campbell has served or serves on advisory groups and boards relating to industry, trade, and academic and governmental organizations involved in the commercialization of science and technology.

Previously, Dr. Campbell was Chairman, CEO, and founder of Celios, a respiratory device company that was acquired by a private investment group and is now selling his proprietary technologies on national television. Prior to founding Celios, Dr. Campbell was co-founder, President, and CEO of Helomics, a personalized healthcare company focused on next-generation therapeutics and diagnostics, co-founder, President, and CEO of SuperNova Diagnostics, and, COO/CEO at EntreMed Pharmaceuticals. Dr. Campbell has prior institutional investment experience as a partner in venture capital, an operating partner, and an industry advisor in private equity and with private investment organizations.

Dr. Campbell has also held senior executive positions at Life Technologies, IGEN International (now Roche), Celera Genomics, and Abbott Laboratories. Dr. Campbell has also held academic positions at Johns Hopkins University and Medical Institutes, Hong Kong University of Science and Tech (HKUST), University of Liverpool (UK), University of Baltimore, and Duquesne University. Dr. Campbell is a veteran of the U.S. Air Force.

Dr. Campbell received his B.Sc. from Norwich University, M.A., Management Sciences and M.B.A., International Business from Webster University, and Doctorate in Science and Technology (D.B.A.) from the University of Liverpool in the United Kingdom.

Education

  • B.Sc., Norwich University

  • M.A. in Management Sciences, Webster University

  • M.B.A. in International Business, Webster University

  • Doctorate in Science and Technology (D.B.A.), University of Liverpool UK

Industry Experience

  • Founder of a respiratory device company (Celios) that was acquired by a private investment group and is now selling his proprietary technologies on national television.
  • Co-founder, President, and CEO of Helomics, a personalized healthcare company on next-generation therapeutics and diagnostics,
  • Co-founder, President, and CEO of SuperNova Diagnostics
  • COO/CEO at EntreMed Pharmaceuticals

Courses Taught

  • BTGY 574 Ethics in Biotechnology
  • BTGY 630 Entrepreneurship and Value Creation in Biotechnology